Do you have T-cell Lymphoma? Is your disease relapsed or refractory and CD5 positive? If so, you may be able to participate in this gene therapy research study to learn more about using your own modified immune cells as possible treatment.

In this study, we are trying to understand how students feel when they look for help after going through sexual misconduct or violence. We also want to find ways to support those who have been affected.

Do you have incurable, metastatic/recurrent head and neck squamous cell carcinoma? If so, you may be able to take part in a study to see if a new drug called petosemtamab is effective. We want to see if petosemtamab works better than the treatments doctors usually use for head and neck squamous cell carcinoma. Compensation provided.

Are you pregnant? Are you planning a scheduled cesarean delivery? If so, you may be able to take part in a study to see if using two antibiotics before a C-section instead of just one can lower the risk of infections. The infections we want to prevent are womb infection, wound infection, or a serious blood infection. Compensation provided.

Have you had an organ transplant or hematopoietic cell transplant and have advanced cutaneous squamous cell carcinoma? If so, you might be eligible to take part in a study to see if an investigation drug, RP1, can help treat your skin cancer.

Participants will meet with me on a recorded Zoom session for about 1 hour in exchange for a $20 Starbucks gift card. During this call, I'll have them complete a few tasks on the cost and financial aid pages of a few different university websites. They will not be asked to provide any personal information to these sites. The purpose of my study is to understand the challenges first-generation students and their families run into when trying to understand the cost of attending college on university websites.

In this study, we want to asses the long-term safety of using a virus to deliver a gene, AAV2-hAQP1, and how effective this gene is at treating dry mouth in people who have received radiation therapy for head and neck cancer.

This study will evaluate BAY 3375968 as a new immunotherapeutic agent in advanced solid tumor settings of high medical need.

In this study, we want to see what happens when one of the drugs in a 4-drug combination called Dara-RVd is given once a week instead of twice a week. We will look at how this timing change affects the outcome of multiple myeloma with autologous stem cell transplantation. This is a hybrid decentralized study where some if not all assessments may be performed close to your home.

Have you been diagnosed with Stage III non-small cell lung cancer? Is your cancer advanced and not able to to removed? If so, you might be able to participate in a study that looks at a study drug to see if it can help the radiation treatment work better against your cancer.